Alpert L Et Al. Aasld 2025. Poster. This information is brought to you by natap and. Approximately 600 posters will be displayed daily in poster form.


Alpert L Et Al. Aasld 2025. Poster

New aasld guidance recommends consideration of all patients with primary sclerosing cholangitis (psc) as potential candidates for clinical trials. Approximately 600 posters will be displayed daily in poster form.

Alpert L Et Al. Aasld 2025. Poster Images References :